Description

Dostinex (cabergoline) tablets 0.5 mg. №8

Ingredients

Active ingredient: Cabergoline 0.5 mg per tablet.

Dosage

Dosage: The usual recommended dose is 0.5 mg twice a week. Dosage may vary depending on the condition being treated. Consult a healthcare professional for personalized dosing.

Indications

Indications: Dostinex tablets are indicated for the treatment of hyperprolactinemia, disorders associated with high levels of prolactin hormone.

Contraindications

Contraindications: Do not use Dostinex if you are allergic to cabergoline or any other ingredients in the product. It is important to inform your healthcare provider about any medical conditions or medications you are taking before starting Dostinex.

Directions

Directions: Take Dostinex exactly as prescribed by your healthcare provider. Do not exceed the recommended dose or frequency of administration.

Scientific Evidence

Cabergoline, the active ingredient in Dostinex, is a dopamine receptor agonist that works by reducing the secretion of prolactin from the pituitary gland. Studies have shown that cabergoline is effective in normalizing prolactin levels and improving symptoms associated with hyperprolactinemia. Research published in the “Journal of Clinical Endocrinology & Metabolism” has demonstrated the efficacy of cabergoline in treating prolactinomas, a type of pituitary tumor that causes elevated prolactin levels.

Additional Information

Dostinex should be stored at room temperature away from moisture and heat. Keep this medication out of reach of children. It is important to attend regular follow-up appointments with your healthcare provider to monitor your response to treatment and adjust the dosage if needed.

Pharmacological Effects: Cabergoline acts on dopamine receptors in the brain, specifically the D2 receptors, to inhibit the secretion of prolactin. By reducing prolactin levels, cabergoline helps restore normal hormonal balance in conditions like hyperprolactinemia.

Clinical Trials: Clinical trials have shown that cabergoline is effective in reducing prolactin levels and improving symptoms in patients with hyperprolactinemia. A study published in “The Journal of Clinical Investigation” demonstrated the superior efficacy of cabergoline compared to bromocriptine, another medication used to treat hyperprolactinemia.